Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma - Wikidata - wikimedia - TriplyDB

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma

http://www.wikidata.org/entity/Q24535655

about

Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience The critically ill patient after hepatobiliary surgery Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a systematic review and meta-analysis Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy Progress of liver resection for hepatocellular carcinoma in Taiwan.Resection of hilar cholangiocarcinoma with left hepatectomy after pre-operative embolization of the proper hepatic artery.Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.Radical resection of hilar bile duct carcinoma and predictors of survival.C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection.Liver resection for cancer.Update on the management of cholangiocarcinoma.Preoperative evaluation with T-staging system for hilar cholangiocarcinoma.Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.Surgical strategy for bile duct cancer: Advances and current limitations.Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection?Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.Perioperative Management of Hilar Cholangiocarcinoma.Survival analysis of cholangiocarcinoma: a 10-year experience in Malaysia.Cholangiocarcinoma: prognostic factors after surgical resection in China.Perineural invasion: a potential reason of hepatocellular carcinoma bone metastasis Hepatocellular apoptosis after hepatectomy in obstructive jaundice in rats.A New Surgical Procedure "Dumbbell-Form Resection" for Selected Hilar Cholangiocarcinomas With Severe Jaundice: Comparison With Hemihepatectomy.Patterns of care and treatment outcomes in older patients with biliary tract cancer Current surgical treatment for bile duct cancer.Surgery for extrahepatic cholangiocarcinoma: predictors of survival.Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy.Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index.Local surgical resection of hilar cholangiocarcinoma: is there still a place?Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009 Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy.Flowcharts for the management of biliary tract and ampullary carcinomas.Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.Clinical analysis of cholangiocarcinoma patients receiving adjuvant radiotherapy.

P2860

Q24541622-5F8A30A6-0774-4C9B-86A5-A02736B38091 Q24794439-72C4315F-E431-460A-A68F-BEA34F4C50D8 Q26751416-08C7CE47-3F32-46C9-B0BE-E6CDAB473F82 Q26823868-726BFFE0-2A43-4CCB-B59E-A89CB4C2816A Q33438991-1259A0C0-F91E-4903-A2B0-F5374E26901B Q33679704-498414F2-684B-4036-8220-988A30AD1CD3 Q33773261-862536B7-D947-4152-BE83-0400F7154AF0 Q33781698-BA176E12-FE3C-4D9E-8AE3-DEB351C48D5F Q33863933-B69FB0FE-CC6D-4A53-8C7F-41B5ED507A60 Q33869507-09431BD2-467A-4C2E-8FE6-FD6C83DA18BC Q33923030-5025C8E3-3F79-44AD-B4E4-A07CDA192AA2 Q33935808-3138CCD6-CD78-4461-B2EA-139D4B71DD8B Q34115047-D812F643-30F4-455A-9F40-D1B52819AD85 Q34153255-92F029A0-A2EF-4D43-B0BB-32D972F22128 Q34225404-47E4968C-EF76-42F8-AE34-34187FD785EC Q34346870-01AE244A-921D-461E-89C2-A06FD8E8B49C Q34528208-6E93B81B-A758-423C-9B3A-0957AB78CB3C Q34578979-E0B247F6-EF79-49EA-8641-2C9708A133B2 Q34629377-1B9CC755-58E5-408C-9324-D031A156CD01 Q35079343-DD0C5BDE-527F-4AF1-96F1-34327B066917 Q35546649-C80AFA8C-136F-4AE0-A764-2428D3BDFD70 Q35607681-8F8BA9E4-AF44-4EB2-9F12-D4204F92AF28 Q35645739-6D2367C0-6BDC-4F4C-85DD-97B3BFAA83BE Q35725890-EFECD3E1-AC4B-40C9-BA53-02926B38061B Q35791442-F46FE1CD-85B1-460E-B61E-354739E9748A Q35792080-5906F8F6-DCAE-4C76-9094-ACD864B3286D Q36180512-A1EB7703-7B11-43C7-82B5-DBF531E60B29 Q36478145-E99F011E-67BF-4D9F-8773-D58D82266833 Q36689150-12D237B6-6ECF-4B0C-85AB-97A461B4245F Q36802509-03A9CD84-1FE5-4FC0-92DD-5C1CA4CFDEA8 Q36824178-4E524173-DEC7-4B39-9C36-4111F1A66A36 Q36828560-5972AC5D-A4A1-42F0-89D5-7A59CB554368 Q37174653-68295BE7-8EAA-4BAE-B332-DB04C8560562 Q37261364-783FB619-5BE0-49E9-AD76-B109B2C2B579 Q37347327-ACF97912-DE42-45C1-A218-B332319B1146 Q37355544-7821376E-75E7-48CC-8E37-BB44857B78A1 Q37408890-41D2C85E-D7BF-4BF8-B430-B6233FE46F73 Q37478212-B7AC1028-DC31-44A3-9CC1-DB901AEBF221 Q37478218-4C4F3717-1BE3-4E5A-B4A9-E52766FD17D3 Q37582417-8D54AF89-DB0C-40F2-8C20-477CF3FF57F2

P2860

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma

http://www.wikidata.org/entity/Q24535655

description

1996 nî lūn-bûn

@nan

1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Factors influencing postoperat ...... n for hilar cholangiocarcinoma

@ast

Factors influencing postoperat ...... n for hilar cholangiocarcinoma

@en

Factors influencing postoperat ...... n for hilar cholangiocarcinoma

@nl

type

label

Factors influencing postoperat ...... n for hilar cholangiocarcinoma

@ast

Factors influencing postoperat ...... n for hilar cholangiocarcinoma

@en

Factors influencing postoperat ...... n for hilar cholangiocarcinoma

@nl

prefLabel

Factors influencing postoperat ...... n for hilar cholangiocarcinoma

@ast

Factors influencing postoperat ...... n for hilar cholangiocarcinoma

@en

Factors influencing postoperat ...... n for hilar cholangiocarcinoma

@nl

P1433

Q24535655-F924797B-1DCF-4C20-841C-6DC0DD4999BB

P1476

Q24535655-4151825D-2232-4E5C-94C5-1EBD1B946890

P2093

Q24535655-085B0F96-D682-4BB4-996B-0CCC5CEEEBBE

Q24535655-0BE04A35-9AAC-472B-A0B9-8A058F21FB67

Q24535655-33F700D9-A9D8-49CA-BF74-540672F65CEC

Q24535655-375D04F9-21C1-46CF-ABB3-CB11021E113E

Q24535655-39C35071-BEFE-426D-A924-54EE1D7FD29E

Q24535655-5AC18123-EECB-4614-9E81-43430BD3485F

Q24535655-609F4016-4BE1-41F6-A96A-4431A686CD43

Q24535655-89411D55-A344-4FAE-8BBA-4495D871CD51

Q24535655-C32C3DAE-BCE6-495F-803B-28ECFA751BCD

P2860

Q24535655-0CBE6EAD-1CDB-415F-A4AB-9B77D3134BB5

Q24535655-1EA30264-34B0-46C0-971A-4C5FF0672E6D

Q24535655-295EFC62-F5CA-4AFB-A69F-D784462FCE1F

Q24535655-3BF0CDB5-106D-4133-ABF7-937F0B57B4F5

Q24535655-3C72F0E5-905A-45C8-8351-1D5634FCBA81

Q24535655-51ADB679-66EA-4AE9-99BF-80C00D588B5D

Q24535655-53FE8C92-7A00-4DEB-B58D-E7C13EAD0115

Q24535655-5F128ABB-F0FA-45AF-89AD-52684E33DCE2

Q24535655-6159CCCB-DD92-466B-8B9A-8A3528240473

Q24535655-627E2FF7-1399-4305-873B-A70C852B3634

P304

Q24535655-1DF1F1CA-FCF7-45BB-B7B3-44AB9B9C7949

P31

Q24535655-08B741BB-42AF-4349-8B3B-76D80DAD2590

P356

Q24535655-AFA8E374-EB41-4AEC-BEAD-721ECFDEA7E4

P407

Q24535655-CA8907DC-AB20-4739-BC4B-7FB45B09DA28

P433

Q24535655-31F09551-A01A-463A-8008-48339BB0FF50

P478

Q24535655-5910A53C-4F7A-41C1-A0D5-D7B99CA2D0BD

P577

Q24535655-C525C217-C57E-415F-AFD3-47985DDEBB01

P5875

Q24535655-D5EE6669-20BA-469A-A373-868FCFF418EA

P698

Q24535655-E16FEE58-4496-4882-8BB6-C8B112996ACA

P921

Q24535655-C48D4422-AEF2-43E1-B1DF-84C37CF2AC80

P932

Q24535655-AF722E10-92AE-4C99-98BC-054E4C2AD8FD

P356

00000658-199604000-00007

P1433

Annals of Surgery

P1476

Factors influencing postoperat ...... n for hilar cholangiocarcinoma

@en

P2093

C C Wu

http://www.w3.org/2001/XMLSchema#string

C H Lee

http://www.w3.org/2001/XMLSchema#string

C H Su

http://www.w3.org/2001/XMLSchema#string

F K P'eng

http://www.w3.org/2001/XMLSchema#string

K L King

http://www.w3.org/2001/XMLSchema#string

S H Tsay

http://www.w3.org/2001/XMLSchema#string

T J Liu

http://www.w3.org/2001/XMLSchema#string

W Y Lui

http://www.w3.org/2001/XMLSchema#string

Y M Shyr

http://www.w3.org/2001/XMLSchema#string

P2860

ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES.

Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients.

Management strategies in resection for hilar cholangiocarcinoma.

The role of chemotherapy in the treatment of bile duct cancer.

Carcinoma of the gallbladder and extrahepatic bile ducts.

Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head.

Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.

Surgical treatment of adenocarcinoma. Location: junction of the right, left, and common hepatic biliary ducts.

Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments.

Carcinoma of the hepatic hilus. Surgical management and the case for resection.

P304

384-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00000658-199604000-00007

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

223

http://www.w3.org/2001/XMLSchema#string

P577

1996-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14566478

http://www.w3.org/2001/XMLSchema#string

P698

8633917

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

1235134

http://www.w3.org/2001/XMLSchema#string